News
Vertex Pharmaceuticals ( VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech 's shares closed the day nearly 3% ...
Mizuho lowered the firm’s price target on Vertiv (VRT) to $115 from $145 and keeps an Outperform rating on the shares. The firm reduced ...
Discover Verizon's record Q1 2025 growth with wireless revenue up 2.7% & strong broadband expansion. Learn about the impact of the Frontier acquisition.
Baird upgraded Verra Mobility (VRRM) to Outperform from Neutral with an unchanged price target of $27. The firm likes Verra’s “strong market ...
A cheap international stock fund. Our research team assigns Silver ... It sorts them by their free-float-adjusted market capitalization and targets firms that land in the top 85% of each country ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Foley currently comanages Fidelity Freedom Index and Fidelity Sustainable target-date strategies, the firm’s 529 offerings, and other multi-asset mandates. She has been an integral member of the ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
2-Year U.S. Treasury Note Continuous Contract $103.809-0.078-0.08% 5-Year U.S. Treasury Note Continuous Contract $108.234-0.125-0.12% 10-Year U.S. Treasury Note Continuous Contract $110.688-0.125 ...
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results